Ifp Advisors, Inc Trevi Therapeutics, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
Number of Shares
0Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TRVI
# of Institutions
176Shares Held
112MCall Options Held
1.07MPut Options Held
425K-
Nea Management Company, LLC Timonium, MD13.2MShares$147 Million6.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.3MShares$114 Million2.96% of portfolio
-
Rubric Capital Management LP New York, NY8.53MShares$94.8 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.83MShares$64.7 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.49MShares$49.9 Million5.2% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $648M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...